文献速递产科

剖宫产术中采用脂质体布比卡因行手术腹横肌平面阻滞:一项先导性随机试验

Surgical transversus abdominis plane block with liposomal bupivacaine at cesarean: a pilot randomized trial.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-12-26

该先导性单盲随机对照试验纳入60名剖宫产产妇,比较手术腹横肌平面阻滞使用脂质体布比卡因复合稀释布比卡因与单用稀释布比卡因的效果。主要结局为术后48小时内累积阿片类药物剂量(吗啡毫克当量),两组中位数分别为2 vs 8(P=.236),无显著差异;出院时阿片类药物片剂处方数干预组少于对照组(P=.029)。作者认为该干预值得在足够把握度的随机试验中进一步评估。

要点

  • 脂质体布比卡因组术后48小时阿片类药物中位累积剂量为2吗啡毫克当量,对照组为8吗啡毫克当量,差异无统计学意义(P=.236)。
  • 出院时阿片类药物片剂处方数干预组少于对照组(P=.029)。
  • 患者满意度两组相似。

核心结论

  • 作者认为,经手术腹横肌平面阻滞给予脂质体布比卡因作为辅助镇痛方式,值得在足够把握度的随机试验中进行严格评估。

研究设计与样本

  • 先导性单盲随机对照试验,在学术医师执业的社区三级转诊医院进行,纳入60名剖宫产产妇。
  • 于剖宫产筋膜关闭前即刻经手术腹横肌平面阻滞给予80 mL稀释布比卡因加脂质体布比卡因或单用稀释布比卡因(每侧40 mL)。
  • 主要结局为术后48小时内累积阿片类药物剂量(吗啡毫克当量),使用Wilcoxon秩和检验比较。
  • 样本量60旨在为未来足够把握度的随机试验提供依据。

主要发现

  • 2021年10月11日至2022年8月29日随机并分析60名参与者:31名分配至脂质体布比卡因加普通布比卡因组(干预组),29名分配至单用普通布比卡因组(对照组)。
  • 干预组术后48小时内阿片类药物中位累积剂量为2吗啡毫克当量(四分位距0-24),对照组为8吗啡毫克当量(四分位距0-40)(P=.236)。
  • 使用≤15吗啡毫克当量阿片类药物的参与者比例干预组为61%,对照组为41%(P=.123);使用零阿片类药物的比例干预组为45%,对照组为34%(P=.399)。
  • 出院时阿片类药物片剂处方总数干预组少于对照组(P=.029)。
  • 干预组与对照组患者满意度相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postcesarean pain control is challenging. In addition to intrathecal morphine, recent studies have shown that liposomal bupivacaine administered via conventional transversus abdominis plane block reduces postcesarean opioid use. However, whether the administration of liposomal bupivacaine via a surgical approach also reduces opioid use is unknown. OBJECTIVE: This study aimed to investigate whether the administration of liposomal bupivacaine via surgical transversus abdominis plane block (TAP block) reduces the cumulative dose of opioids administered in the first 48 hours after cesarean delivery among participants who also receive intrathecal morphine. STUDY DESIGN: This was a pilot single-blind randomized controlled trial of 60 parturients undergoing cesarean delivery at a community tertiary referral hospital staffed by academic physicians. Immediately before fascial closure during cesarean delivery, a total of 80 mL of dilute bupivacaine plus liposomal bupivacaine or dilute bupivacaine alone was administered via surgical transversus abdominis plane block (40 mL on each side). The primary outcome was a median cumulative opioid dose received within the first 48 hours after cesarean delivery measured in morphine milligram equivalents. In addition, opioid use at other time points, pain scores, and participant satisfaction were assessed. A sample size of 60 was determined to be adequate to inform a potential future adequately powered randomized trial. The primary outcome of morphine milligram equivalents and pain scores were compared using a Wilcoxon rank-sum test. RESULTS: Between October 11, 2021, and August 29, 2022, 60 participants were randomized and analyzed: 31 were allocated to liposomal bupivacaine plus regular bupivacaine (intervention group), and 29 were allocated to regular bupivacaine alone (control group). Participants allocated to the intervention group used a median cumulative dose of 2 morphine milligram equivalents of opioids (interquartile range, 0-24) in the first 48 hours compared with 8 morphine milligram equivalents (interquartile range, 0-40) among participants allocated to the control group (P=.236). The percentage of participants who used ≤15 morphine milligram equivalents of opioids was 61% in the intervention arm and 41% in the control arm (P=.123), and the percentage who used zero opioids was 45% in the intervention arm and 34% in the control arm (P=.399). The total number of opioid pills prescribed at discharge was fewer in the intervention arm than in the control arm (P=.029). Patient satisfaction with the intervention group and control group was similar. CONCLUSION: Our pilot study suggests that liposomal bupivacaine administered via surgical transversus abdominis plane block is worth critical evaluation as an adjunctive analgesic modality in an adequately powered randomized trial.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Antony KM, McDonald RC, Gaston L, et al. Surgical transversus abdominis plane block with liposomal bupivacaine at cesarean: a pilot randomized trial. Am J Obstet Gynecol MFM. 2023. PMID: 38154599. doi:10.1016/j.ajogmf.2023.101273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。